Like other GLP-1R agonists, when used alone or treated with non-insulin secretagogues, DUL treatment is associated with weight loss or decreased weight gain (107)
Research indicates it may also have effects on appetite regulation and metabolic processes through its interaction with other melanocortin receptor subtypes
Regular check-ins let your provider adjust your dosage based on how your body responds and that adjustment process is often what separates good outcomes from great ones
In short, your temple area becomes more visible and your forehead becomes wider, even though it is also an unnoticeable stage
Safety, Tolerability & Who These Medications Are For Both medications carry similar side effect profiles: nausea, vomiting, and diarrhea are most common early on
We understand that achieving and maintaining a healthy weight loss Wisconsin is a journey, not a sprint